Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [Corrigendum]
Doherty MK, Morris PG. International Journal of Women’s Health. 2015;7:47–58. On page 50, Table 1, Note section, “MTD 2 mg/m2 but 1.4 mg/m2 recommended for subsequent studies”. Should have been included.On page 50, Table 2, the 4th column heading shou...
Saved in:
Main Authors: | , |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
Call Number: |
A1234.567 |
---|---|
Copy 1 | Available |